Delivery Order SPE2DB22D3102-SPE2DB24FL0CN
Award Date
2/21/24
Potential Completion Date
2/22/24
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,872.64 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product, with a completion date of March 5, 2024. This delivery order is issued under a larger $999,999,999.00 indefinite delivery contract (IDC) between...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,044.43 to Amerisourcebergen Drug Corp, a for-profit pharmaceutical sourcing and distribution company. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a vaccine, with a completion date of March 6, 2024. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $5,508.43 to provide TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a pharmaceutical product, with a period of performance through February 26, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, valued up to $999,999,999.00 with a performance period through...
The U.S. Defense Logistics Agency (DLA) awarded a $1,368.40 firm fixed-price delivery order contract to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the supply of 4564360612 - TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a pharmaceutical product, with an ultimate completion date of April 23, 2024. Amerisourcebergen is a major supplier of pharmaceuticals and medical supplies to the federal government, including the Department of Defense and Department of Veterans...
The Defense Logistics Agency (DLA) awarded a $5,617.92 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4564391256 TYPHIM VI 25 MCG/0.5 ML VIAL 10ML pharmaceuticals. This delivery order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,021,744 units of the pharmaceutical product TYPHIM VI 25 MCG/0.5 ML VIAL 10ML. The contract, valued at $11,809.01, has a period of performance through March 21, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger $999,999,999.00 indefinite delivery contract...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $46,815.50 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccines. The contract has a completion date of March 7, 2024 and was awarded on March 6, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 awarded by...
This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML pharmaceutical products to the Defense Logistics Agency (DLA). The $4,639.10 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of February 5, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product, with a potential value of $5,617.92 and a completion date of February 20, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor and does not have any set-aside designation for this award. This...
The U.S. Defense Logistics Agency (DLA) awarded a $2,052.90 firm fixed price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 25 mcg/0.5 mL TYPHIM VI syringes by May 1, 2024. This award is under Amerisourcebergen's existing $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range...